Dr. Reddy's Recalls Citalopram Tablets Due to Chemical Odor Complaints
Dr. Reddy's is recalling specific lots of Citalopram tablets because patients reported a strong garlic or chemical smell.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations. The hazard is limited to odor complaints without confirmed adverse health consequences, fitting the Moderate criteria for low-risk contamination or precautionary measures.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Citalopram tablets USP, 40mg, 30-count bottles. The recall involves two specific lots: C108376 and C108634, both with an expiration date of 11/13. The product is manufactured by Dr. Reddy's Laboratories Limited in India and distributed nationwide.
The recall was initiated due to complaints reporting a strong garlic odor or strong chemical smell associated with the tablets. This is classified as a chemical contamination issue.
Consumers who have these specific lots of Citalopram tablets should stop using them and contact their healthcare provider or pharmacist for guidance on obtaining a replacement or alternative medication.
The recalled product
- Product
- Citalopram tablets USP, 40mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-344-30
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: C108376
- C108634
- Exp 11/13
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · chemical contamination
See all →- ModerateAvid Medical Recalls 30 DAVINCI LAP/GYN Kits for Lubricant Contamination
FDA (Devices) · 2026-10-14
- ModerateAVID Medical Recalls Craniotomy Packs Due to Potential Lubricant Contamination
FDA (Devices) · 2026-10-14
- ModerateAVID Medical Recalls Plastic Trays Due to Lubricant Contamination
FDA (Devices) · 2026-10-14
- HighFDA Recalls Medical Kits with Contaminated Pericare Wipes
FDA (Devices) · 2026-10-07
- SevereFDA Recalls Medical Kits with Contaminated Pericare Wipes
FDA (Devices) · 2026-10-07
Similar recalls
- ModerateDr. Reddy's Recalls Ondansetron Tablets Due to Failed Impurity Specifications
FDA (Drugs) · 2016-05-18
- ModerateTime-Cap Recalls Ibuprofen Tablets Due to Odor Complaints and CGMP Deficiencies
FDA (Drugs) · 2018-05-02
- ModerateDr. Reddy's Recalls Divalproex Sodium Tablets Due to Humidity Exposure
FDA (Drugs) · 2019-04-24
- ModerateTime-Cap Recalls Ibuprofen Tablets Due to Odor Complaints
FDA (Drugs) · 2018-05-02
- SevereDr. Reddy's Ciprofloxacin Tablets Recalled for Foreign Tablet Contamination
FDA (Drugs) · 2012-08-08
- ModerateDr. Reddy's Recalls Sirolimus Tablets Due to Impurity
FDA (Drugs) · 2016-07-13